Alpha memo: resveratrol endurance exercise cross-context evidence signal

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Replace Receipt 1 with a human endurance/exercise study that actually reports resveratrol results (positive, negative, or null on an endurance-relevant outcome), or drop the 'mechanism_to_human_failure' framing and reframe as a preliminary signal alignment memo rather than a reversal claim.
2. Add a limitations subsection specifying: (a) Receipt 1 is a conference abstract with background/methods only in the bundle, no endpoint results; (b) sample size n=8 in Receipt 1; (c) interspecies dose and duration mismatch (15 mg/kg/day × 4 weeks in aged mice vs 1000 mg/day × 14 days in trained men); (d) different primary endpoints (endurance time-to-exhaustion vs inflammatory cytokines after eccentric exercise).
3. Tone down the one-sentence alpha: replace 'forces the update that the same anchor can fail, reverse, or split by context' with a hedged statement that Receipt 1 does not yet provide outcome data and the contrast is provisional.
4. Add a concrete gaps/next-steps note: a human randomized trial measuring endurance or recovery endpoints under resveratrol, not inflammatory markers alone, is needed to test the cross-context hypothesis.

Major issues

• The memo asserts a 'mechanism_to_human_failure' geometry, but Receipt 1 is a conference abstract (Journal of the International Society of Sports Nutrition 2011, 8(Suppl 1):P15) reporting an ongoing trial with background/methods only — no inflammatory marker results, no failure of effect, no reversal signal are reported in the cited excerpt. The 'forces the update that the same anchor can fail, reverse, or split by context' is not actually evidenced by the bundle and reads as unsupported inference.
• The pair contrast frames Receipt 2 (resveratrol ± exercise improves endurance in aged mice) against Receipt 1 (human eccentric exercise inflammation study), but the title of Receipt 1 concerns inflammatory markers TNF-α/IL-1β/IL-6 after eccentric exercise, not endurance capacity or mitochondrial biogenesis. The 'same anchor' claim is constructed; the two studies measure different endpoints in different species under different dosing and duration, which the memo does not acknowledge as a fundamental comparability problem.
• Receipt 1 is a 2011 conference abstract (proceedings supplement), which is a lower tier of evidence than the memo's framing implies; the memo treats it as a load-bearing counter-receipt without disclosing that no outcome data are available in the bundle.

Minor issues

• The 'Why this is surprising' framing frames this as a novel cross-context contrast, but pairing a positive animal mechanistic study with a human inflammation abstract is a routine compound-screening pattern, not a genuinely surprising geometry.
• The search receipt reports `papers_searched=1456919317` (1.45 billion), which is implausibly large and suggests a logging artifact; should be expressed as a bounded scope statement rather than a literal number.
• The caveats list generic rejection conditions rather than study-specific limitations of the two cited receipts (e.g., n=8 human sample; aged-mouse dose 15 mg/kg/day vs human 1000 mg; abstract-only data; no inflammatory results reported).
• No explicit limitations section on sample size, dose translation, species gap, or the conference-abstract status of Receipt 1.

Reviewer note

The memo attempts a clean cross-context contrast: resveratrol ± exercise improves endurance in aged mice (Receipt 2, 2018, primary research) vs a null/mixed human signal in trained runners (Receipt 1, 2011 conference abstract). The structural pairing is legible, but the bundle does not actually support the central claim. Receipt 1's excerpt contains only background and methods — no TNF-α/IL-1β/IL-6 results are reported, so the memo cannot legitimately claim a human 'failure' or 'reversal.' Receipt 1 is also a low-tier conference proceedings entry (J Int Soc Sports Nutr 2011 suppl), and its primary endpoint (eccentric-exercise inflammation) is not directly comparable to Receipt 2's endpoint (time-to-exhaustion with mitochondrial markers). The 'mechanism_to_human_failure' geometry is constructed rather than observed. With a stronger Receipt 1 (human endurance outcome data), explicit limitations, and hedged conclusions, this could become an acceptable cross-context memo; in current form the central 'forces the update' claim is significantly overclaimed relative to the cited receipts. Recommend revise.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis